SnapMD, Inc., a Los Angeles, CA-based healthcare IT company, completed the first closing of its Series A funding in the amount of $5.3m.
Backers included Shea Ventures, TYLT Labs and Whittier Ventures.
The company intends to use the funds to accelerate business development efforts in direct sales as well as high-valued channel partners, enhance its product developments plans that include core innovations to its cloud-based Virtual Care Management (VCM) private-label telemedicine platform, expanded data integration capabilities and further scale its mobile app solutions.
Led by Dave Skibinski CEO and co-founder and COO George Tierney, SnapMD provides a Virtual Care Management (VCM) telemedicine platform delivered through common devices such as mobile phones, tablets and laptops to enable healthcare providers to engage their patients.
The private-label solution is cloud-based and HIPAA compliant.